Everolimus treatment at 1 and 2 nM significantly reduced the levels of TNF-α compared to the control group, as did INH plus 2 nM everolimus compared to M. tb-containing in vitro granulomas only treated with INH. This evidence concerns the gene TNF and Granuloma.